Physician profile
Fred J Sirotkin
NPI 1821109596
$1,854.10
in general payments reported to CMS, 2019-2025
14 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2021: $258 · 2022: $43.90 · 2023: $859 · 2024: $179 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273 · Entertainment: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,272.68 |
| Entertainment | $127.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $380.52 | 2023 | Kxl System (Refurbished), Kxl1b-Ce-Marked Kxlsystem |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $233.46 | 2021 | |
| Alcon Vision LLC | $227.67 | 2021-2025 | Precision7, Total30 |
| Lkc Technologies, INC. | $139.16 | 2023 | |
| Optos, INC. | $127.48 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Apellis Pharmaceuticals, INC. | $122.25 | 2024 | Syfovre |
| Coopervision INC. | $112.85 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens |
| Oyster Point Pharma, INC. | $107.22 | 2023 | Tyrvaya |
| Abbvie INC. | $106.11 | 2023 | Durysta |
| Sight Sciences, INC. | $79.01 | 2025 | Omni Surgical System |
| Johnson & Johnson Vision Care, INC. | $78.87 | 2019-2025 | |
| Abb Con-Cise Optical Group LLC | $70.00 | 2019 | |
| Optovue, INC. | $41.67 | 2019 | |
| Lombart Brothers, INC. | $27.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Sirotkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.